Callan Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Callan Capital's AMGN Position: Q1 2025 in Review
Callan Capital increased its Amgen (AMGN) stake by 8.2% in Q1 2025, buying an estimated $72.9K and bringing the position to 3,270 shares worth $1.02M. The position accounts for 0.08% of the portfolio, ranked #117.
Callan Capital first reported a position in AMGN in Q1 2020 and has held it in 21 quarters since. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Callan Capital held 3,270 shares of Amgen worth $1.02M as of Q1 2025.
- Callan Capital bought 247 Amgen shares in Q1 2025, an estimated $72.9K.
- Amgen made up 0.08% of Callan Capital's portfolio in Q1 2025, its #117 holding.
- Callan Capital first reported a position in Amgen in Q1 2020 and has held it in 21 quarters since.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.